What this means clinically is that GHK-Cu works on multiple fronts simultaneously
Semaglutide binds to GLP-1 receptors throughout the brain and body, helping regulate appetite, blood sugar, and feelings of satiety, James Simon, MD, an ob-gyn and reproductive endocrinologist and one of the researchers behind the Obesity Pillars study, tells SELF
BPC-157 research themes may include: gastric peptide biology fibroblast marker models angiogenesis marker research nitric oxide signalling inflammatory marker panels collagen organisation studies tissue repair pathway research extracellular matrix studies For the GLOW peptide blend, BPC-157 adds a repair-pathway and inflammatory marker research angle
The safety profile, and efficacy of BPC-157 peptide is still yet to be determined by the drug administration agency and FDA before it is approved as a therapeutic agent for human consumption
People who already have slow stomach emptying don't see such dramatic changes [2]
Also, those who are pregnant or nursing, planning to become pregnant, have a personal or family history of certain cancers, or have experienced angioedema, should not take GLP-1 agonists
